secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kalaris Therapeutics, Inc. (KLRS)
CIK:        0001754068
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0001193125-25-143202
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.08, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Kalaris sets Aug 12, 2025 annual meeting; stockholder proposals due June 30
---------------------------------------------------------------------------

- 2025 annual meeting scheduled for August 12, 2025; postponed from typical anniversary date.
- Rule 14a-8 stockholder proposals must be received by June 30, 2025 to be included in proxy materials.
- Director nominations under by-laws also due June 30, 2025, as meeting delayed over 60 days from prior year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1754068/000119312525143202/0001193125-25-143202-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1754068/000119312525143202/d45802d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-143202

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer